XLerateHealth is a healthcare accelerator that supports innovation in the biomedical technology and life sciences sectors. It operates nationally and is the first healthcare accelerator in the Southeastern United States, according to self-described claims.

XLerateHealth

Propel@YH is Health Innovation Yorkshire & Humber's digital accelerator for innovative healthcare startups, offering support and guidance to enable company growth and market expansion.

Propel@YH

XLerateHealth | 1,128 followers on LinkedIn. XLerateHealth (XLH) is a nationally recognized healthcare accelerator founded in 2012 and headquartered in Louisville KY | XLerateHealth aims to cultivate and grow impactful healthcare innovation in the Midwest, Southeast, and other areas of the country where great innovation often goes unrecognized and underfunded. Our goal is to help early-stage healthcare companies increase the odds of building a successful business. Through our nationally recognized 12-week accelerator, XLH connects selected startups with clinical, academic and business leaders who have the expertise to help the entrepreneurs think through all aspects of commercialization.

Mary Auge

CEO & Co-founder, XLerateHealth

Jackie Willmot

Lawyer, Co-Founder

Bobby Ferreri

Founder | Healthcare Executive | Retail / CPG Product Development

Jake Miller

Join us today at 4:30 in the University of Louisville College of Business auditorium for this free event featuring CoB alumni. More info at https://lnkd.in/ekcgAGRh . #MenardFamilyLectureSeries #FreeEnterprise #HealthcareIndustry #PanelDiscussion #WeAreUofL #UofLAlumni #MyCardinalFlight

Center for Free Enterprise at The University of Louisville

As part of our “Female Founders to Watch” series, we are thrilled to feature Diana Caldwell , MBA, Co-Founder of Amplified Sciences. Amplified Sciences is transforming diagnostic solutions with their innovative PanCystPro technology, designed to detect diseases like pancreatic cancer earlier and more efficiently. Since its founding, Amplified Sciences, Inc. has raised over $5M in funding. This includes a 2021 Series Pre-Seed of $1.78M and a 2024 Series Seed Preferred of $2.6M, co-led by OCA Ventures and Elevate Ventures. They have secured $1.4M from NIH's National Cancer and from the National Science Foundation in highly selective and prestigious SBIR grant competitions. Additionally, Amplified Sciences has also garnered significant recognition as a winner in various highly competitive pitch competitions for young companies throughout the US including Med City Invest (Chicago), RESI (Boston), Most Fundable Companies (LA), Endless Frontier Lab (NYC), Entrepreneurial Allstars (Indianapolis). Diana offers key advice to fellow founders: “Build the right team around you, diverse in skills and expertise, and keep pushing through challenges. If you aren’t hearing five no’s a week during fundraising, you’re probably not doing enough.”

Have you subscribed to our newsletter? XLerateHealth runs a series of newsletters that share information about upcoming commercialization and funding programs, entrepreneur success stories, partnering activities, and more. If you are a healthcare entrepreneur, clinician, faculty member, researcher, or postdoc, and want to learn more about commercializing a healthcare startup, sign up and join our community! Sign up today: https://bit.ly/3SJlyPD

We are delighted to announce the participants for XLerateHealth’s SBIR/STTR 1:1 Coaching Program this fall: Ishanu Chattopadhyay (University of Kentucky), Rani Brooks with BioPhoundry (Tulane University, LA), Brittany Levy with TalkiTourni, LLC (University of Kentucky), Brad Profitt, DC, DPT, DScPT with Ortho-HAB, LLC (Marshall University, WV), and Mark Tseytlin with BioMap5D, LLC (West Virginia University). These participants receive coaching and support from our experts regarding strategies and techniques for submitting a successful SBIR/STTR application.

Join us today for our Healthcare Design Thinking Webinar! Presbyterian College School of Pharmacy, in collaboration with XLerateHealth, invites you to a special interdisciplinary webinar on Healthcare Design Thinking from 5:30 to 7:30 pm ET. This interactive webinar is tailored for healthcare professionals, clinicians, faculty, and students who want to transform clinical challenges into opportunities for innovation. You’ll learn how to apply the design thinking methodology, identify key problems in clinical practice, uncover opportunities, and work toward a prototype solution. By the end of the session, you'll have a clear understanding of the design thinking process and a toolkit to get started! Join us in advancing patient care through the power of design thinking! Sign up here: https://bit.ly/3UzAZOq

Join us for our Healthcare Design Thinking Webinar! Presbyterian College School of Pharmacy, in collaboration with XLerateHealth, invites you to a special interdisciplinary webinar on Healthcare Design Thinking, on Wednesday, November 6, 2024, from 5:30 to 7:30 pm EST. This interactive webinar is tailored for healthcare professionals, clinicians, faculty, and students who want to transform clinical challenges into opportunities for innovation. You’ll learn how to apply the design thinking methodology, identify key problems in clinical practice, uncover opportunities, and work toward a prototype solution. By the end of the session, you'll have a clear understanding of the design thinking process and a toolkit to get started! Mark your calendar and join us in advancing patient care through the power of design thinking! Register here: https://bit.ly/3UzAZOq

XLerateHealth is excited to share that our Healthcare Design Thinking course is up and running at Presbyterian College School of Pharmacy! Students from the schools of Pharmacy, Occupational Therapy, and Business are using a human-centered design approach to innovation, and are working to address real-world critical issues such as: - Optimizing community pharmacy operations based on performance metrics - Improving efficiency in free clinics serving low-income populations - Addressing the needs of individuals with sensory processing issues - Streamlining medication distribution - Mitigating violence in clinical settings From conducting primary market research and analyzing user experiences to generating solutions -- students are actively working on projects that aim to reshape the future of healthcare in rural communities. Thanks to the SBA GAFC award that enabled XLerateHealth to offer entrepreneurial programming and support in the southeast region!

Metric
Company Name	XLerateHealth	Propel@YH
Symbol
MSH ID	COM:XLERATEHEALTH	COM:PROPEL-YH
Market	PRIVATE	PRIVATE
Sector	Commercial & Professional Services	Healthcare & Health Services
Industry	Healthcare & Health Services	Health Technology
Country	US	GB
Stage	Grant
Employee Count
Website	xleratehealth.com	propel-yh.com
LinkedIn	xleratehealth
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	264	182
Web Traffic Growth	-0.96
Valuation
Raised Capital	3.25M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

XLER

COM:XLERATEHEALTH

XLerateHealth

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue